Cancer-associated thromboembolism: could direct-acting oral anticoagulants be a promising therapeutic option? Literature review

Catégorie d'article: Research Article

Publié en ligne: 08 sept. 2020

Pages: 22 - 28

Reçu: 25 mars 2019

Accepté: 28 févr. 2020

DOI: https://doi.org/10.2478/fco-2019-0009

Mots clés

cancer, venous thromboembolic event, CAT, direct oral anticoagulant drugs, DOACs

© 2020 Paraskevi Savvari, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.